论文部分内容阅读
目的 :了解纳洛酮对慢性II型呼吸衰竭的疗效。方法 :治疗组 30例 ,纳洛酮 2mgivgttqd× 12d。对照组 30例 ,可拉明 3支、洛贝林 3支ivgttqd× 12d。结果 :两组有效率、肺功能及血气分析比较均有显著性差异 (P <0 .0 1)。结论 :治疗慢性II型呼吸衰竭 ,纳洛酮明显优于可拉明、洛贝林
Objective: To understand the effect of naloxone on chronic type II respiratory failure. Methods: The treatment group of 30 patients, naloxone 2mgivgttqd × 12d. The control group of 30 cases, 3 cases of Lamine, Lobeline 3 ivgttqd × 12d. Results: There were significant differences between the two groups in the efficiency, pulmonary function and blood gas analysis (P <0.01). CONCLUSIONS: Naloxone is significantly better than kolaamine and lobeline in the treatment of chronic type II respiratory failure